Gurwith, M., Lock, M., Taylor, E. M., Ishioka, G., Alexander, J., Mayall, T., . . . Wright, P. F. (2013). Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: A randomised, double-blind, placebo-controlled, phase 1 study. Elsevier Science ;, The Lancet Pub. Group.
Chicago ZitierstilGurwith, Marc, et al. Safety and Immunogenicity of an Oral, Replicating Adenovirus Serotype 4 Vector Vaccine for H5N1 Influenza: A Randomised, Double-blind, Placebo-controlled, Phase 1 Study. Elsevier Science ;, The Lancet Pub. Group, 2013.
MLA ZitierstilGurwith, Marc, et al. Safety and Immunogenicity of an Oral, Replicating Adenovirus Serotype 4 Vector Vaccine for H5N1 Influenza: A Randomised, Double-blind, Placebo-controlled, Phase 1 Study. Elsevier Science ;, The Lancet Pub. Group, 2013.